China SXT Pharmaceuticals (SXTC) Receivables (2018 - 2026)
China SXT Pharmaceuticals' Receivables came in at $3 million for fiscal Q4 2026 (quarter ended Mar 31, 2026), up 74.8% from $1.72 million a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Receivables (2018 - 2026) Analysis & Trends
Going back to fiscal Q4 2018, China SXT Pharmaceuticals' Receivables data covers 17 quarters.
- Receivables carries a five-year compound annual growth rate of -17.0% (FY2021 to FY2026).
- Going back by fiscal year, Receivables was $1.72 million in FY2025 (+22.9%), $1.4 million in FY2024 (-11.2%), $1.58 million in FY2023 (-66.1%) and $4.65 million in FY2022 (-39.1%).
- The fiscal Q4 2026 figure represents the highest quarterly Receivables since fiscal Q2 2023.
- Year-over-year, Receivables increased in three of the last four quarters, with growth averaging 51.6%.
- The fastest year-over-year change in Receivables over five years came in fiscal Q2 2025 (growth of 111.0%), and the weakest in fiscal Q2 2024 (a decline of 80.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 12.49 Bn |
| 10 | China SXT Pharmaceuticals | 567.53 | -85.95 Mn | - | 3.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Sep 30, 2025 | 4.07 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Sep 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Sep 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 3.62 Mn |
| Sep 30, 2021 | 7.14 Mn |
| Mar 31, 2021 | 5.77 Mn |
| Sep 30, 2020 | 6.32 Mn |
| Mar 31, 2020 | 4.30 Mn |
| Sep 30, 2019 | 8.07 Mn |
| Mar 31, 2019 | 4.39 Mn |
| Sep 30, 2018 | 3.89 Mn |
| Mar 31, 2018 | 2.79 Mn |
API Access
China SXT Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();